Secretory Leucoprotease Inhibitor (SLPI) Promotes Survival during Acute


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
22 11 2022
Historique:
received: 30 09 2022
revised: 07 11 2022
accepted: 16 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Secretory leucoprotease inhibitor (SLPI) has multifaceted functions, including inhibition of protease activity, antimicrobial functions, and anti-inflammatory properties. In this study, we show that SLPI plays a role in controlling pulmonary

Identifiants

pubmed: 36551159
pii: biom12121728
doi: 10.3390/biom12121728
pmc: PMC9776001
pii:
doi:

Substances chimiques

Lipopolysaccharides 0
Secretory Leukocyte Peptidase Inhibitor 0
SLPI protein, human 0
Slpi protein, mouse 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Antimicrob Agents. 2017 Sep;50(3):427-435
pubmed: 28666755
Thorax. 2001 Jan;56(1):36-41
pubmed: 11120902
Infect Immun. 1996 Nov;64(11):4520-4
pubmed: 8890201
Physiol Genomics. 2005 May 11;21(3):324-36
pubmed: 15701729
Biochem Biophys Res Commun. 1999 Jan 27;254(3):614-7
pubmed: 9920787
J Exp Med. 2005 Dec 19;202(12):1659-68
pubmed: 16352738
Biochim Biophys Acta. 2005 Sep 30;1745(3):310-7
pubmed: 16112212
Am J Respir Cell Mol Biol. 1998 Dec;19(6):875-80
pubmed: 9843921
J Innate Immun. 2017;9(3):250-261
pubmed: 28222444
J Immunol. 2008 Mar 15;180(6):4032-9
pubmed: 18322212
Biochem Biophys Res Commun. 1997 Dec 18;241(2):305-11
pubmed: 9425267
Eur Respir J. 1998 Nov;12(5):1200-8
pubmed: 9864022
Am J Physiol Lung Cell Mol Physiol. 2001 Jan;280(1):L79-87
pubmed: 11133497
J Immunol. 1999 Mar 15;162(6):3653-62
pubmed: 10092827
Cytokine Growth Factor Rev. 2021 Jun;59:22-35
pubmed: 33602652
Front Immunol. 2019 Apr 04;10:664
pubmed: 31019507
J Immunol. 2011 Apr 1;186(7):4433-42
pubmed: 21335488
Curr Opin Pulm Med. 2013 May;19(3):216-28
pubmed: 23524477
Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L51-8
pubmed: 10645890
J Exp Med. 2003 Mar 3;197(5):669-74
pubmed: 12615907
J Immunol. 2007 Nov 15;179(10):6588-95
pubmed: 17982048
J Clin Invest. 1992 Oct;90(4):1296-301
pubmed: 1357002
J Biol Chem. 2002 Sep 13;277(37):33648-53
pubmed: 12084717
Nat Commun. 2018 Apr 19;9(1):1560
pubmed: 29674674
Biochem Biophys Res Commun. 1998 Jul 30;248(3):904-9
pubmed: 9704025
Eur Respir J. 1999 May;13(5):1029-36
pubmed: 10414400
Infect Immun. 1999 Sep;67(9):4485-9
pubmed: 10456890
Br J Pharmacol. 2009 Oct;158(4):1048-58
pubmed: 19845686
Infect Immun. 2004 Jun;72(6):3684-7
pubmed: 15155685
Am J Respir Cell Mol Biol. 1994 Dec;11(6):733-41
pubmed: 7946401
Mucosal Immunol. 2018 Jan;11(1):35-49
pubmed: 28422188
Respir Med. 2007 Sep;101(9):1947-53
pubmed: 17574828
Exp Lung Res. 2010 Aug;36(6):373-80
pubmed: 20653472
Am J Pathol. 1999 Jan;154(1):239-47
pubmed: 9916938
Gastroenterology. 2000 Jun;118(6):1061-71
pubmed: 10833481
J Leukoc Biol. 1997 Jun;61(6):695-702
pubmed: 9201260
J Infect Dis. 1997 Sep;176(3):740-7
pubmed: 9291323
J Exp Med. 1999 Aug 16;190(4):535-42
pubmed: 10449524
Eur Respir J. 2017 Jul 13;50(1):
pubmed: 28705940
Crit Care Med. 2000 May;28(5):1276-82
pubmed: 10834665
Eur J Pharm Biopharm. 2005 Oct;61(3):214-8
pubmed: 16039104
Am Rev Respir Dis. 1993 Feb;147(2):442-7
pubmed: 8094278
Mucosal Immunol. 2016 May;9(3):669-76
pubmed: 26376365
Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1056-60
pubmed: 8105734
Am J Pathol. 2000 Mar;156(3):1033-9
pubmed: 10702419
Am Rev Respir Dis. 1986 May;133(5):882-90
pubmed: 3706899
Genes Cells. 2021 Oct;26(10):807-822
pubmed: 34379860
Am J Physiol. 1993 Sep;265(3 Pt 1):L286-92
pubmed: 8105697
Cell. 1997 Feb 7;88(3):417-26
pubmed: 9039268
Infect Immun. 2002 Sep;70(9):4908-16
pubmed: 12183536

Auteurs

Megan Osbourn (M)

Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.

Aoife M Rodgers (AM)

Department of Biology, The Kathleen Lonsdale Institute for Human Health Research, Maynooth University, W23 F2H6 Maynooth, Ireland.

Alice V Dubois (AV)

Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.

Donna M Small (DM)

The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7BL, UK.

Fiachra Humphries (F)

Department of Biology, The Kathleen Lonsdale Institute for Human Health Research, Maynooth University, W23 F2H6 Maynooth, Ireland.

Nezira Delagic (N)

Department of Biology, The Kathleen Lonsdale Institute for Human Health Research, Maynooth University, W23 F2H6 Maynooth, Ireland.

Paul N Moynagh (PN)

Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.
Department of Biology, The Kathleen Lonsdale Institute for Human Health Research, Maynooth University, W23 F2H6 Maynooth, Ireland.

Sinéad Weldon (S)

Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.

Clifford C Taggart (CC)

Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.

Rebecca J Ingram (RJ)

Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH